1SMITH SC JR,ALLEN J,BLAIR SN,et al.AHA/ ACC guidelines for secondary prevention for patients with coronary and other ath -erosclerotic vascular disease:2006 UPdate[J].J Am Coll Cardiol,2006,47(10):2130-2139. 被引量：1
5HALLAS J,DALL M,ANDIRES A,et al.Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding:population based case-control study[J].BMJ,2006,333(7571):726. 被引量：1
7Lanas A,Garcia-Rodriguez LA,Arroyo MT,et al.Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-ocygenase-2 inhibitors,traditional non-aspirin non-steroidal anti-inflammatory drugs,aspirin and combinations[J].Gut,2006,55:1731-1738. 被引量：1
8King SB 3rd,Smith SC Jr,Hirshfeld JW Jr,et al.2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines:2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention,writing on behalf of the 2005 writing committee[J].Circulation,2008,117(2):261-295. 被引量：1
9Silber S,Albertsson P,Aviles FF,et al.Guidelines for percutaneous coronary interventions.The task force for percutaneous coronary interventions of the european society of cardiology[J].Eur Heart J,2005,26(8):804-847. 被引量：1
10Chin MW,Yong G,Bul sara MK,et al.Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention:a case control study[J].Am J Gastroenterol,2007,102(11):2411-2416. 被引量：1
